Beta-lactam antibiotics play a pivotal role in addressing microbial threats, demonstrating versatility in treating a wide array of bacterial infections. Carbapenems, a potent subgroup, exhibit broad-spectrum activity against gram-positive and gram-negative bacteria, making them valuable in severe infections. Monobactams, such as aztreonam, are notable for their specificity against gram-negative aerobes, minimizing collateral damage to beneficial flora. Despite their efficacy, the emergence of beta-lactamases poses a challenge, prompting continuous research for novel compounds and combination therapies to combat resistance. The ongoing evolution of beta-lactam antibiotics underscores their significance in modern antimicrobial strategies.
Title : The role of the humoral innate immune system in evasion of streptococcus pyogenes infections
Francis J. Castellino, University of Notre Dame, United States
Title : Global environmental changes and mosquito-borne diseases in coastal areas
Ranjan Ramasamy, IDFISH Technology, United States
Title : The impact of global antibiotic resistance on the healthcare system, public health, environment and society
Reza Nassiri, Michigan State University, United States
Title : Current topics of adult COVID-19, Influenza, and RS virus patients in Japan
Seki Masafumi, Saitama Medical University International Medical Center, Japan
Title : Novel nanotechnology and its potential applications
Stephen Hsu, Augusta University, United States
Title : 2000 years of pandemics: Past, present and future
Claudia Ferreira, Biophytis Sorbonne, France